BETA DRUGS LIMITED Share Price

BETA DRUGS LIMITED Share Price

NSE: BETA
|
Pharmaceuticals

₹ 1,666.00

-₹178.30 (-9.67%)
1D
Last updated 13 Oct, 2026, 15:07 IST

BETA DRUGS LIMITED Share Price Today

As of 13 Oct 2026, BETA DRUGS LIMITED share price is ₹1,666.00. The stock opened at ₹1,845.00, compared to its previous close of ₹1,844.30. During today's trading session, BETA DRUGS LIMITED share price moved in the range of ₹1,665.20 to ₹1,859.40, with an average price of ₹1,762.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹990.10 and a high of ₹2,807.90. On the performance front, BETA DRUGS LIMITED share price has increased by 32.26% over the last six months and is up 6.55% on a year-on-year basis.

₹1,665.20
9.67% down today
₹1,859.40
1D LOW
1D HIGH

BETA DRUGS LIMITED Returns Calculator

Volume
1,11,250
Average traded price
₹1,716.94
Last traded time
03:07:26 13 Oct
Last traded quantity
30
Circuit
L
H
₹1,475.50
₹2,213.10
52-week
L
H
₹990.10
₹2,807.90
Mkt Cap Cr
2,044.57
P/E
44.19
P/B
8.32
ROA
9.33%
ROE
16.95%
ROCE
17.46%
EV/EBITDA
23.46
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Beta Drugs Ltd has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Beta Drugs Ltd appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
Beta Drugs Ltd revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%21.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%56.28
Torrent Pharmaceuticals1,77,251.4282.5521.164.87%25.49%13.85%38.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%14.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%53.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%17.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%15.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%25.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%12.47
Lupin89,628.8316.033.9614.47%23.76%24.88%9.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About BETA DRUGS LIMITED

BETA DRUGS LIMITED Share Price
ISIN
INE351Y01019
Sector Market Cap
₹ 2,044.57 Cr

Beta Drugs Limited is an India-based oncology medicine manufacturing company. The Company specializes in the intricate field of complex chemical synthesis for anti-cancer bulk drugs and finished dosages. The Company operates through one segment, Pharmaceuticals. Its product category includes cosmeceutical products and oncology products. The cosmeceutical products include La’Thrix, BACINOX, URTICALM, HUMIDA, NUSPLASH, UVIREX, ADVIBE, SENSIBAR, and RECAPRO. The oncology products include Temozad(Temozolomide), ADVIN(Vinorelbine), ADSIDE(Etoposide), ADRIB(Doxorubicin), ADCOV(Leucovorin calcium), ADPLATIN(Oxaliplatin), INOTAD(Irinotecan), ADCIST(Cisplatin), ADCARB(Carboplatin), ERLOTAD(Erlotinib), ADOXI(Docetaxel), AMGICIN(Gemcitabine), ADPAXIL(Paclitaxel), ADMIDE(Bicalutamide), and others. The Company's subsidiaries include Adley Lab Limited and Adley Formulations Private Limited.

BETA DRUGS LIMITED Financial Highlights

  • Revenue: BETA DRUGS LIMITED reported revenue of ₹396.01 crore in FY26 vs ₹368.80 crore in FY25. It showed an increase of 7.38% on a yearly basis.
  • Operating Profit: BETA DRUGS LIMITED reported an operating profit of ₹54.39 crore in FY26 vs ₹56.97 crore in FY25. It showed a decrease of 4.53% on a year-on-year basis.
  • Net Profit: BETA DRUGS LIMITED reported a net profit of ₹41.48 crore in FY26 vs ₹42.42 crore in FY25. It showed a decrease of 2.22% on a yearly basis.

BETA DRUGS LIMITED Quarterly Result Highlights

  • BETA DRUGS LIMITED reported revenue of ₹127.13 crore in Jun 2026, compared with ₹96.85 crore in Mar 2026, representing an increase of 31.26% on a quarter-on-quarter (QoQ) basis.
  • BETA DRUGS LIMITED reported an operating profit of ₹22.04 crore in Jun 2026, compared with ₹11.83 crore in Mar 2026, representing an increase of 86.31% on a quarter-on-quarter (QoQ) basis.
  • BETA DRUGS LIMITED reported a profit of ₹16.49 crore in Jun 2026, compared with ₹9.05 crore in Mar 2026, reflecting an increase of 82.21% on a QoQ basis.
  • The earnings per share (EPS) of BETA DRUGS LIMITED stood at ₹42.02 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
59.10%
FII
1.02%
Other DII
6.23%
Retail and other
33.65%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20251.14%
Mar 20260.90%
May 20262.95%
Jun 20261.02%
1 day
-5.43%
1 week
-7.97%
1 month
-12.94%
1 year
+6.55%
3 years
+94.32%
5 years
+219.03%
Day
Open / Close
Change %
12 Oct 26
₹1,950.00 / ₹1,844.30
-5.43%
09 Oct 26
₹1,910.00 / ₹1,950.20
+2.75%
08 Oct 26
₹2,000.00 / ₹1,898.00
-4.69%
07 Oct 26
₹1,980.00 / ₹1,991.40
-0.50%
Show more

BETA DRUGS LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹362.36₹295.71₹227.11₹183.84
Other Income₹6.44₹1.36₹0.75₹0.76
Total Revenue₹368.79₹297.07₹227.87₹184.59
Total Expenses₹307.25₹248.32₹186.81₹150.29
Profit Before Tax₹56.97₹48.75₹41.06₹34.30
Tax₹14.55₹12.32₹10.34₹9.47
Profit After Tax₹42.42₹36.44₹30.72₹24.83
EPS - Basic₹42.02₹37.90₹31.95₹25.82
EPS - Diluted₹42.02₹37.90₹31.95₹25.82

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹61.54₹48.75₹41.06₹34.30
Income before WC changes₹55.17₹44.51₹43.08₹39.40
Change in Assets-₹34.82-₹40.71-₹28.89-₹22.02
Change in Liabilities₹15.79₹27.14₹9.19₹12.25
Change in WC-₹19.03-₹13.58-₹19.69-₹9.77
Cash flow from Operations₹36.14₹30.93₹23.38₹29.63
Cash flow from Investing-₹35.72-₹13.97-₹19.07-₹21.75
Cash flow from Financing₹117.97-₹7.49-₹2.47-₹0.97
Total Cash Flow₹118.39₹9.47₹1.84₹6.90
Cash (Start of the year)₹28.63₹19.16₹17.32₹10.42
Cash (End of the year)₹147.02₹28.63₹19.16₹17.32

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹105.16₹76.23₹70.74₹60.89
Current Assets₹331.08₹177.87₹127.68₹96.96
Total Assets₹436.23₹254.10₹198.42₹157.85
Current Liabilities₹102.73₹84.67₹63.02₹48.97
Net Current Asset₹228.35₹93.20₹64.67₹47.99
Non-Current Liabilities₹136.41₹12.31₹12.52₹16.54
Equity Capital₹197.10₹157.12₹122.88₹92.34
Total Equity & Liabilities₹436.23₹254.10₹198.42₹157.85

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹220.20₹197.62₹157.87₹124.85
Other Income₹6.19₹1.73₹1.04₹0.86
Total Revenue₹226.39₹199.35₹158.92₹125.70
Total Expenses₹200.98₹169.87₹133.71₹105.54
Profit Before Tax₹20.84₹29.48₹25.21₹20.16
Tax₹5.41₹7.55₹6.39₹5.92
Profit After Tax₹15.43₹21.94₹18.82₹14.25
EPS - Basic₹15.29₹22.82₹19.57₹14.82
EPS - Diluted₹15.29₹22.82₹19.57₹14.82

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹25.41₹29.48₹25.21₹20.16
Income before WC changes₹17.86₹23.19₹25.63₹23.28
Change in Assets-₹11.85-₹19.27-₹20.03-₹11.89
Change in Liabilities₹12.03₹17.26₹4.62₹7.38
Change in WC₹0.18-₹2.01-₹15.41-₹4.51
Cash flow from Operations₹18.04₹21.19₹10.23₹18.76
Cash flow from Investing-₹21.46-₹11.02-₹5.82-₹12.72
Cash flow from Financing₹118.20-₹0.76-₹2.19₹1.27
Total Cash Flow₹114.79₹9.40₹2.21₹7.31
Cash (Start of the year)₹27.20₹17.79₹15.58₹8.27
Cash (End of the year)₹141.99₹27.20₹17.79₹15.58

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹76.21₹56.80₹49.04₹48.14
Current Assets₹240.31₹113.67₹85.00₹62.76
Total Assets₹316.52₹170.47₹134.04₹110.90
Current Liabilities₹57.53₹47.66₹31.47₹25.85
Net Current Asset₹182.78₹66.01₹53.53₹36.91
Non-Current Liabilities₹129.96₹6.80₹6.32₹7.59
Equity Capital₹129.04₹116.01₹96.26₹77.46
Total Equity & Liabilities₹316.52₹170.47₹134.04₹110.90
* All values are in INR Crore
Qty
Bid
11
1667.1
416
1666
2
1665.5
33
1665.2
11
1665.1
Ask
Qty
1667.5
20
1667.6
5
1668.1
2
1668.2
7
1668.3
52
Bid Total: 473
Ask Total: 86
Buy orders: 85%
Sell orders: 15%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
32.35
Neutral
ATR (14)
106.16
Neutral
STOCH(9,6)
30
Neutral
STOCH RSI (14)
0
Bullish
ADX(9)
20.83
Bearish
UO(9)
42.22
Neutral
ROC(12)
-15.7
Bearish
WillR(14)
-73.4
Neutral
Period
Simple value
Exponential vaue
5D
1937.06
1927.58
10D
1992.08
1976.57
20D
2045.96
2037.76
50D
2212.08
2104.42
100D
2066.58
2014.66
Volume trend — traded volume by day
13 Oct1L
12 Oct0L
9 Oct1L
8 Oct0L
7 Oct0L
6 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
BETA DRUGS LIMITED Share Price
BETA DRUGS LIMITED
Pharmaceuticals
Add Stock
Add Another

BETA DRUGS LIMITED Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.